A well being employee prepares a dose of the Pfizer-BioNTech Covid-19 vaccine on the Senja-Cashew Neighborhood Centre Vaccination Centre in Singapore on March 8, 2021.
Wei Leng Tay | Bloomberg | Getty Photographs
Beforehand, solely folks 16 and above had been allowed to obtain the shot. The vaccine developed by Moderna is simply given to people who’re 18 years and above.
Singapore’s Well being Sciences Authority (HSA) approved the usage of the Pfizer-BioNTech vaccine for youngsters between 12 and 15 below the Pandemic Particular Entry Route for emergency therapeutic merchandise.
The nation’s knowledgeable committee on Covid vaccines assessed the security, efficacy and tolerability of the vaccine earlier than endorsing the interim authorization by HSA.
“The information confirmed that the Pfizer-BioNTech COVID-19 vaccine demonstrated excessive efficacy in keeping with that noticed within the grownup inhabitants,” the ministry of well being mentioned in a press launch.
“Its security profile can be in keeping with the recognized security profile within the grownup inhabitants and the requirements set for different registered vaccines used within the immunization towards different ailments,” it added.
Singapore additionally introduced that people between the ages of 40 to 44 could be invited to register for his or her vaccinations from Wednesday this week.
The immunization program will proceed to be rolled out in five-year age bands, progressively transferring to youthful teams, the press launch mentioned.
“Our provide of vaccines has been steadily coming in, however stays restricted given excessive international demand,” it mentioned.
Nonetheless, the well being ministry mentioned it is on monitor to finish the vaccination program by the tip of the yr “if our provides arrive as scheduled.”
As of Might 17, Singapore has administered greater than 3.4 million doses of the vaccine. Not less than 1.4 million people have acquired their second dose.
That is breaking information. Please verify again for updates.